Ingredient

Linagliptin

Linagliptin is an active ingredient used for blood glucose control in the treatment of type 2 diabetes.

See medicines used for Chronic Conditions
All medicines
213
Single ingredient
59
Combination
154
Prescription medication
213

MFDS ingredient code M252996

What does it do?

Linagliptin belongs to the DPP-4 inhibitor class of diabetes medications. This ingredient is used in pharmaceuticals to promote insulin secretion and lower blood glucose levels. It primarily helps control blood glucose in patients with type 2 diabetes.

Linagliptin inhibits the DPP-4 enzyme in the body, preventing the breakdown of incretin hormones. As a result, insulin secretion increases and blood glucose is effectively controlled. Additionally, it also exhibits effects that suppress the rise in blood glucose levels.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Unlike other DPP-4 inhibitors, linagliptin is primarily metabolized in the liver and has minimal renal excretion, making it relatively safe for use in patients with impaired kidney function. This characteristic distinguishes it from other similar ingredients.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

213 total

View more

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Combined ingredients

Ingredients used together with this ingredient in combination products.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.